US Stock MarketDetailed Quotes
OSTX OS Therapies
- 4.170
- -0.010-0.24%
Close Sep 9 16:00 ET
- 4.150
- -0.020-0.48%
Post 20:01 ET
87.09MMarket Cap-13280P/E (TTM)
4.180High4.050Low76.99KVolume4.180Open4.180Pre Close318.04KTurnover4.81%Turnover RatioLossP/E (Static)20.88MShares4.90052wk High-3.22P/B6.67MFloat Cap2.51052wk Low--Dividend TTM1.60MShs Float4.900Historical High--Div YieldTTM3.11%Amplitude2.510Historical Low4.130Avg Price1Lot Size
OS Therapies Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | -6.03%-881.19K | -49.87%-641.73K | 20.71%-3.01M | -831.05K | 55.44%-428.19K | 13.86%-3.79M | -960.91K | -4.4M |
| Net income from continuing operations | 37.83%-1.56M | 21.01%-1.46M | -24.57%-7.79M | ---2.51M | -35.56%-1.85M | 15.71%-6.25M | ---1.36M | ---7.42M |
| Depreciation and amortization | -13.66%695 | 595.00%695 | 424.22%4.22K | --805 | --100 | 0.00%805 | --0 | --805 |
| Other non cash items | -46.58%446.53K | -21.03%578.74K | 82.51%2.76M | --835.93K | 194.20%732.84K | -38.00%1.51M | --249.09K | --2.44M |
| Change In working capital | -72.64%229.07K | -65.32%237.83K | 112.94%2.02M | --837.27K | 349.68%685.84K | 64.85%947.33K | --152.52K | --574.67K |
| -Change in payables and accrued expense | -72.64%229.07K | -65.32%237.83K | 112.94%2.02M | --837.27K | 349.68%685.84K | 64.85%947.33K | --152.52K | --574.67K |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | -6.03%-881.19K | -49.87%-641.73K | 20.71%-3.01M | ---831.05K | 55.44%-428.19K | 13.86%-3.79M | ---960.91K | ---4.4M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 0 | 0 | -99.50%1.15K | -19 | 1.15K | 15.17%230.88K | 0 | 200.47K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---11.93K |
| Net other investing changes | ---- | ---- | -99.50%1.15K | --0 | --1.15K | 8.70%230.88K | ---- | --212.41K |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | --0 | --0 | -99.50%1.15K | ---19 | --1.15K | 15.17%230.88K | --0 | --200.47K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 66.81%875.89K | 15.10%702.98K | -21.33%2.87M | 525.08K | -33.97%610.78K | 19.74%3.65M | 925K | 3.05M |
| Net issuance payments of debt | 84.62%900K | 9.81%851K | -17.44%3.16M | --487.5K | -16.22%775K | 29.63%3.82M | --925K | --2.95M |
| Net other financing activities | -164.17%-24.12K | 9.87%-148.02K | -65.20%-284.18K | --37.58K | ---164.23K | -272.02%-172.02K | ---- | --100K |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 66.81%875.89K | 15.10%702.98K | -21.33%2.87M | --525.08K | -33.97%610.78K | 19.74%3.65M | --925K | --3.05M |
| Net cash flow | ||||||||
| Beginning cash position | -71.78%100.23K | -77.27%38.98K | 112.26%171.48K | --355.21K | 112.26%171.48K | -93.45%80.79K | --80.79K | --1.23M |
| Current changes in cash | 98.27%-5.31K | -66.66%61.25K | -246.10%-132.5K | ---305.99K | 611.68%183.73K | 107.87%90.69K | ---35.91K | ---1.15M |
| End cash Position | 92.85%94.93K | -71.78%100.23K | -77.27%38.98K | --49.22K | 691.48%355.21K | 112.26%171.48K | --44.88K | --80.79K |
| Free cash flow | -6.03%-881.19K | -49.87%-641.73K | 20.71%-3.01M | ---831.07K | 55.44%-428.19K | 14.09%-3.79M | ---960.91K | ---4.41M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
